# Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd – FDA Inspection, Aug 9, 2024

Source: https://www.keypedia.com/records/fda_inspections/hangzhou-zhongmeihuadong-pharmaceutical-jiangdong-co-ltd/e2b6fa8e-d8de-4edf-8bf3-8b868f6f495c
Source feed: FDA_Inspections

> FDA inspection 1248443 of Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd, August 09, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1248443
- Company Name: Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd
- Inspection Date: 2024-08-09
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/helen-verdel/f6caf5a8-74f5-4833-bd00-5579b369f4f9)

Company: https://www.keypedia.com/companies/hangzhou-zhongmeihuadong-pharmaceutical-jiangdong-co-ltd/a849e5dc-0723-4fe8-9485-5440caae744b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c